Study Details

8409-184-Group 13

Back To Current Studies

Healthy Non-Smoking Adults Needed 

Study Number

8409-184-Group 13

Group

13

Gender

both

Age

18-65

Location

Dallas, Texas

Compensation

$7,658

Study Dates

Mar. 10 - Jul. 15, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

• Healthy Non-Smoking Adults, age 18-65

• BMI (body mass index) 18-30

• Join us for a stay of 8 nights followed by 11 outpatient visits

• Compensation up to $7658 may be provided for time and participation

Details

Screening: Feb 20, 21, 24, 25, 26, 27, 28

Check-in: Mar 10

Check-out: Mar 18

Outpatient Visits: Mar 21, 25; Apr 1, 8, 22; May 6, 20; Jun 3, 17; Jul 1, 15

Study Number

8409-184-Group 13

Group

13

Gender

both

Age

18-65

Location

Dallas, Texas

Compensation

$7,658

Study Dates

Mar. 10 - Jul. 15, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

• Healthy Non-Smoking Adults, age 18-65

• BMI (body mass index) 18-30

• Join us for a stay of 8 nights followed by 11 outpatient visits

• Compensation up to $7658 may be provided for time and participation

Details

Screening: Feb 20, 21, 24, 25, 26, 27, 28

Check-in: Mar 10

Check-out: Mar 18

Outpatient Visits: Mar 21, 25; Apr 1, 8, 22; May 6, 20; Jun 3, 17; Jul 1, 15

Calculate Your BMI!

Calculate Your BMI!